Professor Sweedler received his B.S. degree in Chemistry from the University of California at Davis in 1983, and his Ph.D. from the University of Arizona in 1989. Thereafter, he was an NSF Postdoctoral Fellow at Stanford University before joining the faculty at...
The Mehta Lab is combining expertise in synthetic biology and synthetic chemistry to develop fundamentally novel, modular platforms to engineer selectivity in targeting cancers. They are using principles of directed evolution and biomolecule delivery platforms to...
Steven C. Zimmerman’s research is broadly based at the interface of organic chemistry, chemical biology, and materials chemistry. Zimmerman has worked on molecular recognition and supramolecular chemistry for over 30 years and over the same span periodically...
Professor Murphy received two BS degrees, one in chemistry and one in biochemistry, from the University of Illinois in 1986. She received her PhD from the University of Wisconsin in 1990. From 1990-1993, she was first an NSF and then an NIH postdoctoral...
Douglas Mitchell and his lab group have focused on understanding the chemical biology of natural products with early efforts focusing on thiazole/oxazole-containing peptides. The Mitchell lab is multidisciplinary and employs a combination of bioinformatics,...
Jongsook Kim Kemper’s lab is studying transcriptional and epigenetic control of metabolism, using multidisciplinary approaches, ranging from cell-free to animal and human studies and utilizing cutting-edge genomic, proteomic, and metabolomic approaches. The...
John Katzenellenbogen directs a research program that intersects chemistry, biology, and medical applications with a particular focus on the action of estrogens in breast cancer and androgens in prostate cancer. His interests are in addressing key problems in...
Lawrence Schook is an international scholar of comparative genomics who has developed the Oncopig Cancer Model, a biomedical cancer model to help medical professionals better understand and treat the disease. The Oncopig Cancer Model (OCM) is a next-generation large...
David Sarlah is an organic chemist, using the discovery of new reactivities and the guiding principles of chemistry to aid in the creation of cancer therapies. Through collaborations with CCIL members, Sarlah has successfully developed several enabling methodologies...
Dr. Burke’s research interests are in the area of organic chemistry with a specific focus on the synthesis and study of small molecules with protein-like functions. His research includes “Lego Chemistry”, which is synthesizing small molecules to be used for scientific...
